On the stock market since 2013, it operates in the world of health and science. It has 1,861 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 33% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $3.2B would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Bets Against the Stock: The number of investors betting on a fall stands out.
The stock trades 52% below its peak. The market has trimmed its expectations for the company.
The net profit margin is 22% — still a thick cushion, though costs have been eating into it lately.
Over the last 3 years, sales grew about 23% a year on average.
There is $3.3B in the vault; even if every debt were paid off, $3.2B would remain.
The weight of investors positioned for a fall can be felt in the market. Council score: 2/10.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 3/10.
On our five-subject report card, BVNRY sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: BVNRY is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.